Trip report

Last updated

A trip report, also known as a psychedelic experience report, is a written account of a subjective psychedelic experience by a person who has taken a psychedelic or other hallucinogenic drug. [1] [2] [3] They are often published on online websites like Erowid, Bluelight, Lycaeum, Drugs Forum, and Reddit, among others, with Erowid's Experience Vaults containing thousands of trip reports. [2] [3] [4] [5] [6]

Contents

Among the most famous trip reports are those of chemist Albert Hofmann when he discovered LSD, including Bicycle Day (April 19, 1943) and his initial accidental lower-dose exposure a few days earlier on April 16, 1943. [7] [8] [9] Writer Aldous Huxley's The Doors of Perception (1954) is a book-length trip report about his first experience with mescaline provided by psychiatrist Humphrey Osmond. [3] Chemist Alexander Shulgin's books PiHKAL (1991) [10] and TiHKAL (1997) [11] contain short trip reports for hundreds of psychedelic drugs. [12] [13]

In the 2020s, researchers have started to analyze trip reports as part of scientific research into the effects of psychedelics. [2] [5] [14] [15] As an example, the pharmaceutical company Mindstate Design Labs processed 70,000 online trip reports with artificial intelligence (AI) and selected 5-MeO-MiPT as a candidate with unique subjective effects for development as a potential pharmaceutical medication. [16] [17] [15]

See also

References

  1. ↑ Bååth, Jonas; Nordgren, Johan (27 October 2022). "Trip Reports". Routledge Handbook of Intoxicants and Intoxication. London: Routledge. pp. 328–341. doi:10.4324/9780429058141-26. ISBN   978-0-429-05814-1 . Retrieved 26 April 2025.
  2. 1 2 3 Miceli McMillan, Riccardo; Reynolds, Jack; Fernandez, Anthony (25 November 2024). "The phenomenology of psychedelic temporality: current knowledge, open questions, and clinical applications" . Philosophical Psychology: 1–28. doi:10.1080/09515089.2024.2433522. ISSN   0951-5089 . Retrieved 26 April 2025.
  3. 1 2 3 Tagliazucchi E (2022). "Language as a Window Into the Altered State of Consciousness Elicited by Psychedelic Drugs". Front Pharmacol. 13: 812227. doi: 10.3389/fphar.2022.812227 . PMC   8980225 . PMID   35392561.
  4. ↑ Bogenschutz MP (2000). "Drug information libraries on the Internet". J Psychoactive Drugs. 32 (3): 249–258. doi:10.1080/02791072.2000.10400447. PMID   11061675.
  5. 1 2 Luke, David (2022). "Anomalous Psychedelic Experiences: At the Neurochemical Juncture of the Humanistic and Parapsychological". Journal of Humanistic Psychology. 62 (2): 257–297. doi: 10.1177/0022167820917767 . ISSN   0022-1678.
  6. ↑ Mosurinjohn S, Roseman L, Girn M (2023). "Psychedelic-induced mystical experiences: An interdisciplinary discussion and critique". Front Psychiatry. 14: 1077311. doi: 10.3389/fpsyt.2023.1077311 . PMC   10171200 . PMID   37181886.
  7. ↑ Olive, M. Foster (2008). "History of LSD". LSD. Infobase Publishing. pp. 21–33. ISBN   978-0-7910-9709-0 . Retrieved 26 April 2025.
  8. ↑ Albert Hofmann (15 August 1994). "History of the Discovery of LSD". In Ladewig, D.; Pletscher, A. (eds.). Fifty Years of LSD: Current Status and Perspectives of Hallucinogens. CRC Press. ISBN   978-1-85070-569-7 . Retrieved 26 April 2025.
  9. ↑ Hofmann, Albert (2013) [1980]. LSD: My Problem Child. OUP Oxford. p. 22. ISBN   978-0-19-963941-0.
  10. ↑ Alexander T. Shulgin; Ann Shulgin (1991). PiHKAL: A Chemical Love Story (1st ed.). Berkeley, CA: Transform Press. ISBN   978-0-9630096-0-9. OCLC   25627628.
  11. ↑ Alexander T. Shulgin; Ann Shulgin (1997). TiHKAL: The Continuation (1st ed.). Berkeley, CA: Transform Press. ISBN   978-0-9630096-9-2. OCLC   38503252.
  12. ↑ Walker, Scott R.; Pullella, Glenn A.; Piggott, Matthew J.; Duggan, Peter J. (5 July 2023). "Introduction to the chemistry and pharmacology of psychedelic drugs". Australian Journal of Chemistry. 76 (5): 236–257. doi: 10.1071/CH23050 . ISSN   0004-9425 . Retrieved 26 April 2025.
  13. ↑ Sumnall HR, Evans-Brown M, McVeigh J (2011). "Social, policy, and public health perspectives on new psychoactive substances". Drug Test Anal. 3 (7–8): 515–523. doi:10.1002/dta.310. PMID   21744515.
  14. ↑ Ballentine G, Friedman SF, Bzdok D (March 2022). "Trips and neurotransmitters: Discovering principled patterns across 6850 hallucinogenic experiences". Sci Adv. 8 (11): eabl6989. Bibcode:2022SciA....8L6989B. doi:10.1126/sciadv.abl6989. PMC   8926331 . PMID   35294242.
  15. 1 2 Meissen, Andrew (20 September 2024). "Mindstate Uses AI to Design "Next-Gen" Psychedelics Combined With 5-MeO-MiPT". Lucid News - Psychedelics, Consciousness Technology, and the Future of Wellness. Retrieved 10 November 2024.
  16. ↑ Bayer, Max (13 March 2024). "After crunching 70k 'trip reports', Mindstate looks to test first AI-derived psychedelic on humans". Fierce Biotech. Retrieved 10 November 2024.
  17. ↑ Microdose NewsDesk (10 September 2024). "Mindstate Design Labs AI-Designed Trial Gets FDA Approval". Microdose. Retrieved 10 November 2024.



This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.